Literature DB >> 14607948

TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice.

Udaikumar M Padigel1, Nacksung Kim, Yongwon Choi, Jay P Farrell.   

Abstract

Blockade of TNF-related activation-induced cytokine (TRANCE)-receptor activator of NF-kappaB (RANK) interaction reverses healing in CD40L(-/-) mice infected with Leishmania major. Although previous studies demonstrated a requirement for CD40-CD40L interaction in production of IL-12 and the development of resistance to Leishmania infection, we recently showed that CD40L(-/-) mice control infection when inoculated with low numbers of parasites and that cells from these mice produce IL-12. Here, we show that in vivo treatment with a TRANCE receptor fusion protein results in a decrease in numbers of IL-12 producing cells as well as a shift from a dominant Th1 to Th2 type response in infected mice. These results demonstrate that CD40L(-/-) mice use the TRANCE-RANK costimulatory pathway to promote IL-12 production and the activation of a protective Th1 type response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607948     DOI: 10.4049/jimmunol.171.10.5437

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Interleukin-12: an update on its immunological activities, signaling and regulation of gene expression.

Authors:  Jianguo Liu; Shanjin Cao; Sunjung Kim; Elaine Y Chung; Yoichiro Homma; Xiuqin Guan; Violeta Jimenez; Xiaojing Ma
Journal:  Curr Immunol Rev       Date:  2005-06

Review 2.  Do RANKL inhibitors (denosumab) affect inflammation and immunity?

Authors:  S Ferrari-Lacraz; S Ferrari
Journal:  Osteoporos Int       Date:  2010-06-23       Impact factor: 4.507

3.  CD40/CD154 interactions are required for the optimal maturation of skin-derived APCs and the induction of helminth-specific IFN-gamma but not IL-4.

Authors:  James P Hewitson; Gavin R Jenkins; Paul A Hamblin; Adrian P Mountford
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 4.  CD40 and the immune response to parasitic infections.

Authors:  Carlos S Subauste
Journal:  Semin Immunol       Date:  2009-07-18       Impact factor: 11.130

5.  Immunomodulation by blockade of the TRANCE co-stimulatory pathway in murine allogeneic islet transplantation.

Authors:  Anne Wojtusciszyn; Axel Andres; Philippe Morel; Solange Charvier; Mathieu Armanet; Christian Toso; Yongwon Choi; Domenico Bosco; Thierry Berney
Journal:  Transpl Int       Date:  2009-05-15       Impact factor: 3.782

6.  RANKL-RANK interaction in immune regulatory systems.

Authors:  Taishin Akiyama; Miho Shinzawa; Nobuko Akiyama
Journal:  World J Orthop       Date:  2012-09-18

Review 7.  Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

Authors:  Ann E Kearns; Sundeep Khosla; Paul J Kostenuik
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

Review 8.  Regulation of T cell-associated tissues and T cell activation by RANKL-RANK-OPG.

Authors:  Matthew C Walsh; Yongwon Choi
Journal:  J Bone Miner Metab       Date:  2021-01-12       Impact factor: 2.626

9.  Infections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?

Authors:  N B Watts; C Roux; J F Modlin; J P Brown; A Daniels; S Jackson; S Smith; D J Zack; L Zhou; A Grauer; S Ferrari
Journal:  Osteoporos Int       Date:  2011-09-03       Impact factor: 4.507

Review 10.  New Therapeutic Tools to Shape Monocyte Functional Phenotypes in Leishmaniasis.

Authors:  Natália S Vellozo; Thaís S Rigoni; Marcela F Lopes
Journal:  Front Immunol       Date:  2021-06-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.